º¹¸· Åõ¼® ½ÃÀå ±âȸ, ¼ºÀå ÃËÁø¿äÀÎ, »ê¾÷ µ¿Ç⠺м® ¹× ¿¹Ãø(2025-2034³â)
Peritoneal Dialysis Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034
»óǰÄÚµå : 1801882
¸®¼­Ä¡»ç : Global Market Insights Inc.
¹ßÇàÀÏ : 2025³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 140 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,850 £Ü 6,787,000
PDF & Excel (Single User License) help
PDF, Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,050 £Ü 8,466,000
PDF & Excel (Multi User License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,350 £Ü 11,684,000
PDF & Excel (Enterprise User License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

º¹¸· Åõ¼® ¼¼°è ½ÃÀå ±Ô¸ð´Â 2024³â¿¡ 131¾ï ´Þ·¯·Î Æò°¡µÇ¾ú°í, CAGR4.8%·Î ¼ºÀåÇÏ¿© 2034³â±îÁö´Â 209¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

½ÅÀå °ü·Ã ÁúȯÀÇ ¹ßº´·ü Áõ°¡, ÀçÅà Åõ¼® ¼Ö·ç¼ÇÀÇ µµÀÔ Áõ°¡, Åõ¼® Ä¡·á¸¦ Áö¿øÇÏ´Â À¯¸®ÇÑ »óȯ Á¦µµ µîÀ» ÁÖ¿ä ¿äÀÎÀ¸·Î ²ÅÀ» ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ±âÁ¸ Ç÷¾×Åõ¼®º¸´Ù ºñ¿ë È¿À²¼ºÀÌ ³ô°í, ½ÅÀå ±âÁõÀÚ ºÎÁ· Çö»óÀÌ Áö¼ÓµÇ°í ÀÖ´Â Á¡µµ ½ÃÀå ¼ö¿ä¸¦ ´õ¿í Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù. º¹¸·Åõ¼®Àº ¸»±â½ÅºÎÀü(ESRD)À̳ª ±Þ¼º½ÅÀåÁúȯÀ» ¾Î°í Àִ ȯÀÚµéÀÇ »ý¸íÀ¯Áö ¿ä¹ýÀ¸·Î, ½ÅÀåÀÌ ±â´ÉÀ» »ó½ÇÇßÀ» ¶§ ³ëÆó¹°°ú °úµµÇÑ ¼öºÐÀ» È¿°úÀûÀ¸·Î Á¦°ÅÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀçÅà ȯÀÚ °ü¸® Ä¡·á·ÎÀÇ ÀüȯÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ¾÷°è »óȲÀ» °è¼Ó Çü¼ºÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Àα¸ °í·ÉÈ­¿Í ¸¸¼º½ÅÀ庴 ȯÀÚ Áõ°¡´Â Àü ¼¼°è PD ¼Ö·ç¼ÇÀÇ º¸±Þ¿¡ Å©°Ô ±â¿©Çϰí ÀÖ½À´Ï´Ù.

º¹¸·Åõ¼® Market-IMG1

2024³â ¼Ò¸ðǰ ºÎ¹®ÀÇ Á¡À¯À²Àº 63.6%¿´½À´Ï´Ù. ÀÌ´Â ESRD ȯÀÚ Áõ°¡¿Í Åõ¼®¾×, PD Ä«Å×ÅÍ, ±âŸ °ü·Ã ¼Ò¸ðǰ µî PD¿¡ ÇʼöÀûÀÎ ºÎǰ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ±âÀÎÇÑ °ÍÀ¸·Î ºÐ¼®µË´Ï´Ù. ÀçÅà ġ·á·ÎÀÇ ÀüȯÀÌ ÀÌ·¯ÇÑ Ãß¼¼¿¡ Å« ¿µÇâÀ» ¹ÌÄ¡°í ÀÖÀ¸¸ç, ȯÀÚ°¡ È¥ÀÚ¼­ Á¤±âÀûÀÎ Åõ¼®À» Çϱâ À§Çؼ­´Â ÀÌ·¯ÇÑ Á¦Ç°ÀÇ ¾ÈÁ¤ÀûÀÎ °ø±ÞÀÌ ÇÊ¿äÇϱ⠶§¹®ÀÔ´Ï´Ù. ȯÀÚÀÇ ¼Ò¸ðǰ¿¡ ´ëÇÑ ÀÇÁ¸µµ Áõ°¡´Â ¸¸¼º ½ÅºÎÀü°ú ±Þ¼º ½ÅºÎÀü, ƯÈ÷ ³ëÀÎ Àα¸ Áõ°¡·Î ÀÎÇØ ¸¸¼º ½ÅºÎÀü ¹× ±Þ¼º ½ÅºÎÀü À¯º´·ü Áõ°¡·Î ÀÎÇØ ´õ¿í µÎµå·¯Áö°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Àα¸Åë°èÇÐÀû º¯È­·Î ÀÎÇØ ½Å·Ú¼ºÀÌ ³ô°í °¡Á¤¿¡¼­ »ç¿ëÇÒ ¼ö ÀÖ´Â Åõ¼®¾×¿¡ ´ëÇÑ ¼ö¿ä°¡ Áö¼ÓÀûÀ¸·Î Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¹üÀ§
°³½Ã ¿¬µµ 2024³â
¿¹Ãø ¿¬µµ 2025-2034³â
°³½Ã ±Ý¾× 131¾ï ´Þ·¯
¿¹Ãø ±Ý¾× 209¾ï ´Þ·¯
CAGR 4.8%

Áö¼ÓÀû ¿Ü·¡ Åõ¼®(CAPD) ºÐ¾ß´Â 2024³â 76¾ï ´Þ·¯ÀÇ ¸ÅÃâÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2025³âºÎÅÍ 2034³â±îÁö ¿¬Æò±Õ 4.6%ÀÇ ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. CAPD´Â ÀÚµ¿ Åõ¼®±â¿¡ ´ëÇÑ Á¢±ÙÀÌ Á¦ÇÑµÈ Áö¿ª¿¡¼­´Â ¿©ÀüÈ÷ ¼±È£µÇ´Â ¼±ÅÃÀÔ´Ï´Ù. ÀÌ ¹æ¹ýÀº ȯÀÚ°¡ ±â°è¿¡ ÀÇÁ¸ÇÏÁö ¾Ê°í ÇÏ·ç¿¡ ¿©·¯ ¹ø ¼öµ¿À¸·Î Åõ¼®À» ÇÒ ¼ö ÀÖÀ¸¸ç, Àú·ÅÇÑ °¡°Ý, »ç¿ë ÆíÀǼº, Á¤»óÀûÀÎ ÀÏ»ó »ýȰÀ» À¯ÁöÇÒ ¼ö ÀÖ´Â À¯¿¬¼ºÀ» Á¦°øÇÕ´Ï´Ù. Åõ¼® ¼¾ÅÍ¿¡ ´ëÇÑ ÀÇÁ¸µµ¸¦ ³·Ã߸鼭 ȯÀÚ°¡ ÀÚ½ÅÀÇ Ä¡·á¿¡ ´ëÇÑ ÅëÁ¦·ÂÀ» ³ôÀÏ ¼ö ÀÖ´Ù´Â Á¡¿¡¼­ ÀαⰡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù.

¹Ì±¹ º¹¸·Åõ¼® ½ÃÀåÀº 2024³â 40¾ï 4,000¸¸ ´Þ·¯ ±Ô¸ð·Î 2025³âºÎÅÍ 2034³â±îÁö ¿¬Æò±Õ 3.5% ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. PD°¡ ±¹³»¿¡¼­ ¹Þ¾Æµé¿©Áö°í ÀÖ´Â ÀÌÀ¯´Â Ä¡·áÀÇ À¯¿¬¼º, ÀçÅÃÅõ¿©, »îÀÇ Áú Çâ»ó µî ȯÀÚ Áß½ÉÀÇ ÀåÁ¡ÀÌ Àֱ⠶§¹®ÀÔ´Ï´Ù. ÀÇ·á ¼­ºñ½º Á¦°ø¾÷üµéÀº ƯÈ÷ ÀÇ·á ½Ã½ºÅÛÀÌ °¡Ä¡ ±â¹Ý Ä¡·á ¸ðµ¨À» äÅÃÇÔ¿¡ µû¶ó ¼¾ÅÍ ±â¹Ý Ç÷¾× Åõ¼®¿¡ ´ëÇÑ È¿°úÀûÀÎ ´ë¾ÈÀ¸·Î PD¸¦ ±ÇÀåÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Áõ°¡ Ãß¼¼´Â ÀçÅÃÅõ¼®À» ¼±ÅÃÇϴ ȯÀÚ¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö°í ±³À° ÇÁ·Î±×·¥ÀÌ °­È­µÇ¸é¼­ ´õ¿í °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù.

¼¼°è º¹¸·Åõ¼® ½ÃÀåÀ» Àû±ØÀûÀ¸·Î Çü¼ºÇϰí ÀÖ´Â »óÀ§±Ç ±â¾÷À¸·Î´Â Terumo, Vantive(Baxter), Diaverum(M42), BD, B. Braun, Davita Kidney Care, Polymed, Utah Medical Products, Vivance, Fresenius Medical Care, medCOMP, Mozarc Medical µîÀÌ ÀÖ½À´Ï´Ù. Vivance, Fresenius Medical Care, medCOMP, Mozarc Medical µîÀÌ ÀÖ½À´Ï´Ù. ½ÃÀå ÁöÀ§¸¦ È®º¸ÇÏ°í °æÀï·ÂÀ» °­È­Çϱâ À§ÇØ º¹¸·Åõ¼® ºÐ¾ßÀÇ ±â¾÷µéÀº ¸î °¡Áö Àü·«Àû ÀÌ´Ï¼ÅÆ¼ºê¸¦ Àû±ØÀûÀ¸·Î ÃßÁøÇϰí ÀÖ½À´Ï´Ù.

¿©±â¿¡´Â º¸´Ù Áøº¸µÈ »ç¿ëÀÚ Ä£È­ÀûÀÎ °¡Á¤¿ë Åõ¼® ¼Ö·ç¼ÇÀ¸·Î Á¦Ç° Æ÷Æ®Æú¸®¿À¸¦ È®ÀåÇϰí, ¼­ºñ½º Á¦°ø ³×Æ®¿öÅ©¸¦ °­È­Çϱâ À§ÇØ ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü¿ÍÀÇ ÆÄÆ®³Ê½ÊÀ» °­È­ÇÏ´Â µîÀÇ ³ë·ÂÀÌ Æ÷ÇԵ˴ϴÙ. ¸¹Àº ±â¾÷µéÀÌ È¿À²¼º°ú ¾ÈÀü¼ºÀ» ³ôÀÎ Â÷¼¼´ë Åõ¼®±â¸¦ °³¹ßÇϱâ À§ÇØ ¿¬±¸°³¹ß¿¡ ¸¹Àº ÅõÀÚ¸¦ Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Àü·«Àû M&A´Â Áö¸®Àû ¹üÀ§¸¦ ³ÐÈ÷°í Àü¹®Àû ¿ª·®À» ÅëÇÕÇÏ´Â µ¥ Ȱ¿ëµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ƯÈ÷ °³¹ßµµ»ó±¹¿¡¼­ ȯÀÚµéÀÇ µµÀÔ°ú ¼øÀÀµµ¸¦ ³ôÀ̱â À§ÇÑ ±³À° ÇÁ·Î±×·¥ ¹× ÀÎ½Ä °³¼± Ä·ÆäÀεµ ½ÃÀ۵Ǿú½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ¾÷°è ÀλçÀÌÆ®

Á¦4Àå °æÀï ±¸µµ

Á¦5Àå ½ÃÀå Ã߻ꡤ¿¹Ãø : Ä«Å×°í¸®º°, 2021³â-2034³â

Á¦6Àå ½ÃÀå Ã߻ꡤ¿¹Ãø : À¯Çüº°, 2021³â-2034³â

Á¦7Àå ½ÃÀå Ã߻ꡤ¿¹Ãø : º´»óº°, 2021³â-2034³â

Á¦8Àå ½ÃÀå Ã߻ꡤ¿¹Ãø : ÃÖÁ¾ ¿ëµµº°, 2021³â-2034³â

Á¦9Àå ½ÃÀå Ã߻ꡤ¿¹Ãø : Áö¿ªº°, 2021³â-2034³â

Á¦10Àå ±â¾÷ °³¿ä

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The Global Peritoneal Dialysis Market was valued at USD 13.1 billion in 2024 and is estimated to grow at a CAGR of 4.8% to reach USD 20.9 billion by 2034. Key drivers fueling this expansion include the rising incidence of kidney-related conditions, increasing adoption of home-based dialysis solutions, and favorable reimbursement structures supporting dialysis treatment. Additionally, cost efficiency over traditional hemodialysis, combined with a persistent shortfall in kidney donors, further bolsters market demand. Peritoneal dialysis, a life-sustaining therapy for individuals facing end-stage renal disease (ESRD) and acute kidney injury, allows for the effective removal of waste and excess fluid when the kidneys lose function. A growing shift toward patient-managed care at home continues to shape the industry landscape. Moreover, the aging population and a growing number of patients affected by chronic kidney issues are contributing heavily to the uptake of PD solutions globally.

Peritoneal Dialysis Market - IMG1

In 2024, the consumables segment held a 63.6% share. This dominance is largely attributed to a higher volume of ESRD cases and increasing demand for essential PD components such as dialysate solutions, PD catheters, and other related consumables. The shift toward home-based therapies has significantly influenced this trend, as patients require a steady supply of these products to conduct regular sessions independently. This growing patient reliance on consumables is magnified by the rising prevalence of both chronic and acute kidney failures, particularly within the elderly population. These demographic changes continue to push demand for dependable, home-compatible dialysis solutions.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$13.1 Billion
Forecast Value$20.9 Billion
CAGR4.8%

The continuous ambulatory peritoneal dialysis (CAPD) segment generated USD 7.6 billion in 2024 and is forecasted to grow at a 4.6% CAGR during 2025-2034. CAPD remains a preferred choice in regions where access to automated dialysis equipment is limited. This approach enables patients to perform manual exchanges multiple times a day without relying on machines, offering affordability, ease of use, and the flexibility to maintain normal routines. Its growing popularity stems from its ability to empower patients with greater control over their treatment while reducing dependence on dialysis centers.

United States Peritoneal Dialysis Market was valued at USD 4.04 billion in 2024 and is expected to grow at a 3.5% CAGR from 2025 through 2034. The rising acceptance of PD in the country is due to its patient-centric benefits, including treatment flexibility, at-home administration, and improved quality of life. Healthcare providers are increasingly recommending PD as a viable alternative to center-based hemodialysis, especially as the healthcare system embraces value-based care models. This upward trend is further fueled by growing awareness and better training programs for patients opting for home dialysis.

The top-tier companies actively shaping the Global Peritoneal Dialysis Market are Terumo Corporation, Vantive (Baxter), Diaverum (M42), BD, B. Braun, Davita Kidney Care, Polymed, Utah Medical Products, Vivance, Fresenius Medical Care, medCOMP, and Mozarc Medical. To secure their market positions and enhance competitiveness, companies operating in the peritoneal dialysis sector are actively pursuing several strategic initiatives.

These include expanding their product portfolios with more advanced and user-friendly dialysis solutions tailored for home use, as well as forming partnerships with healthcare providers to strengthen service delivery networks. Many firms are investing heavily in R&D to develop next-generation PD devices with improved efficiency and safety profiles. Additionally, strategic mergers and acquisitions are being used to widen geographic reach and integrate specialized capabilities. Training programs and awareness campaigns are also being launched to boost patient adoption and adherence, particularly in developing regions.

Table of Contents

Chapter 1 Methodology and Scope

Chapter 2 Executive Summary

Chapter 3 Industry Insights

Chapter 4 Competitive Landscape, 2024

Chapter 5 Market Estimates and Forecast, By Category, 2021 - 2034 ($ Mn)

Chapter 6 Market Estimates and Forecast, By Type, 2021 - 2034 ($ Mn)

Chapter 7 Market Estimates and Forecast, By Disease Condition, 2021 - 2034 ($ Mn)

Chapter 8 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

Chapter 10 Company Profiles

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â